Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.

Zhao SJ, Wang DH, Li YW, Han L, Xiao X, Ma M, Wan DC, Hong A, Ma Y.

Int J Nanomedicine. 2017 Mar 20;12:2143-2160. doi: 10.2147/IJN.S130566. eCollection 2017.

2.

High-Fat Diet Augments VPAC1 Receptor-Mediated PACAP Action on the Liver, Inducing LAR Expression and Insulin Resistance.

Nakata M, Zhang B, Yang Y, Okada T, Shintani N, Hashimoto H, Yada T.

J Diabetes Res. 2016;2016:9321395. doi: 10.1155/2016/9321395. Epub 2016 Dec 1.

3.

The Mechanism Research of Qishen Yiqi Formula by Module-Network Analysis.

Zheng S, Zhang Y, Qiao Y.

Evid Based Complement Alternat Med. 2015;2015:497314. doi: 10.1155/2015/497314. Epub 2015 Aug 24.

4.

Pituitary adenylate cyclase activating peptide (PACAP) participates in adipogenesis by activating ERK signaling pathway.

Arsenijevic T, Gregoire F, Chiadak J, Courtequisse E, Bolaky N, Perret J, Delporte C.

PLoS One. 2013 Sep 9;8(9):e72607. doi: 10.1371/journal.pone.0072607. eCollection 2013.

5.

PACAP Inhibits β-cell Mass Expansion in a Mouse Model of Type II Diabetes: Persistent Suppressive Effects on Islet Density.

Inoue H, Shintani N, Sakurai Y, Higashi S, Hayata-Takano A, Baba A, Hashimoto H.

Front Endocrinol (Lausanne). 2013 Mar 11;4:27. doi: 10.3389/fendo.2013.00027. eCollection 2013.

6.

Central PACAP mediates the sympathetic effects of leptin in a tissue-specific manner.

Tanida M, Hayata A, Shintani N, Yamamoto N, Kurata Y, Shibamoto T, Morgan DA, Rahmouni K, Hashimoto H.

Neuroscience. 2013 May 15;238:297-304. doi: 10.1016/j.neuroscience.2013.02.016. Epub 2013 Feb 27.

7.
8.

Stimulation of the hypothalamic ventromedial nuclei by pituitary adenylate cyclase-activating polypeptide induces hypophagia and thermogenesis.

Resch JM, Boisvert JP, Hourigan AE, Mueller CR, Yi SS, Choi S.

Am J Physiol Regul Integr Comp Physiol. 2011 Dec;301(6):R1625-34. doi: 10.1152/ajpregu.00334.2011. Epub 2011 Sep 28.

9.

VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.

Moody TW, Ito T, Osefo N, Jensen RT.

Curr Opin Endocrinol Diabetes Obes. 2011 Feb;18(1):61-7. doi: 10.1097/MED.0b013e328342568a. Review.

10.

Effect of VPAC1 Blockade on Adipose Tissue Formation and Composition in Mouse Models of Nutritionally Induced Obesity.

Lijnen HR, Freson K, Hoylaerts MF.

J Obes. 2010;2010. pii: 359527. doi: 10.1155/2010/359527. Epub 2010 Jun 30.

11.

Expression analysis of PAC1-R and PACAP genes in zebrafish embryos.

Alexandre D, Alonzeau J, Bill BR, Ekker SC, Waschek JA.

J Mol Neurosci. 2011 Jan;43(1):94-100. doi: 10.1007/s12031-010-9397-y. Epub 2010 Jun 5.

Supplemental Content

Support Center